HKSE - Delayed Quote HKD

Golden Throat Holdings Group Company Limited (6896.HK)

4.760
-0.050
(-1.04%)
At close: 4:08:05 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,185,004
1,185,004
961,377
992,014
820,543
Cost of Revenue
290,820
290,820
263,658
271,094
242,807
Gross Profit
894,184
894,184
697,719
720,920
577,736
Operating Expense
465,064
465,064
348,225
353,079
354,268
Operating Income
429,120
429,120
349,494
367,841
223,468
Net Non Operating Interest Income Expense
9,886
9,886
13,427
6,259
7,371
Pretax Income
437,278
437,278
361,021
375,993
236,847
Tax Provision
118,647
118,647
110,859
94,775
49,204
Net Income Common Stockholders
318,631
318,631
250,162
281,218
187,643
Diluted NI Available to Com Stockholders
318,631
318,631
250,162
281,218
187,643
Basic EPS
0.43
--
0.34
0.38
0.25
Diluted EPS
0.43
--
0.34
0.38
0.25
Basic Average Shares
739,302
--
739,302
739,302
739,302
Diluted Average Shares
739,302
739,302
739,302
739,302
739,302
Total Expenses
755,884
755,884
611,883
624,173
597,075
Net Income from Continuing & Discontinued Operation
318,631
318,631
250,162
281,218
187,643
Normalized Income
318,631
318,631
250,162
281,218
186,170.992
Interest Income
25,249
25,249
24,126
16,553
15,346
Interest Expense
15,363
15,363
10,699
10,294
7,975
Net Interest Income
9,886
9,886
13,427
6,259
7,371
EBIT
452,641
452,641
371,720
386,287
244,822
EBITDA
489,068
489,068
410,753
424,931
281,797
Reconciled Cost of Revenue
290,820
290,820
263,658
271,094
242,807
Reconciled Depreciation
36,427
36,427
39,033
38,644
36,975
Net Income from Continuing Operation Net Minority Interest
318,631
318,631
250,162
281,218
187,643
Total Unusual Items Excluding Goodwill
--
--
847
0
1,858
Total Unusual Items
--
--
847
0
1,858
Normalized EBITDA
489,068
489,068
410,753
424,931
279,939
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
385.992
12/31/2021 - 7/15/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

2161.HK JBM (Healthcare) Limited
2.240
+0.45%
 
YIHCF YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
0.5500
0.00%
 
0239.HK PAK FAH YEOW
2.310
+0.43%
 
AGY.L Allergy Therapeutics plc
7.10
-1.39%
 
STX.L Shield Therapeutics plc
2.4000
-5.88%
 
1681.HK CONSUN PHARMA
9.540
-1.75%
 
UPC Universe Pharmaceuticals INC
5.00
+4.66%
 
AVDL Avadel Pharmaceuticals plc
9.49
+1.06%
 
UTHR United Therapeutics Corporation
304.70
-1.07%
 
ALVO Alvotech
9.88
+5.33%